rxstat › Classes › Antiadrenergic Agents, Centrally Acting

Antiadrenergic Agents, Centrally Acting: shortage status in Canada

2 of the 3 antiadrenergic agents, centrally acting rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Clonidine Partial shortage 4 of 9 reported products affected Methyldopa Partial shortage 1 of 3 reported products affected · est. return Nov 20, 2026 Guanfacine (Intuniv) No current shortage

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.